Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413764
Status:
COMPLETED
Last Update Posted:
2022-02-04
First Post:
2006-12-19
Brief Title:
Efficacy of Tibolone Versus Transdermal E2NETA on Sexual Function in Naturally Postmenopausal Women P06089
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Double Dummy Trial to Compare the Effects Tibolone and Transdermal Continuous Combined EstradiolNorethisterone on Sexual Desire and Arousal in Postmenopausal Women With Sexual Dysfunction
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Tibolone has been registered for treatment of menopausal symptoms It is however not known what the effects are of tibolone in postmenopausal women diagnosed with sexual dysfunction This is important because there is currently no approved treatment of libido problems in postmenopausal women Therefore the primary aim of this study was to compare the effects of tibolone with an estrogenprogestogen skin patch in postmenopausal women diagnosed sexual dysfunction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| C-1774 | None | None | None |